We are live on ! Find out more
HR

Howe & Rusling Portfolio holdings

AUM $1.53B
1-Year Est. Return 21.45%
This Fund
S&P 500
This Quarter Est. Return
+0.71%
1 Year Est. Return
+21.45%
3 Year Est. Return
+66.11%
5 Year Est. Return
+83.74%
10 Year Est. Return
+259.21%
AUM
$408M
AUM Growth
+$10.7M
Cap. Flow
+$13.7M
Cap. Flow %
3.35%
Top 10 Hldgs %
25.67%
Holding
987
New
183
Increased
285
Reduced
172
Closed
127

Sector Composition

Rank Sector Weight
1 Industrials 16.38%
2 Healthcare 12.76%
3 Financials 12.57%
4 Technology 12.37%
5 Consumer Discretionary 9.94%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GWW icon
151
W.W. Grainger
GWW
$60.7B
$173K 0.04%
684
NVS icon
152
Novartis
NVS
$294B
$173K 0.04%
2,276
+479
+27% +$34.9K
COF icon
153
Capital One
COF
$136B
$171K 0.04%
2,210
-33
-1% -$2.42K
FLG
154
Flagstar Bank National Association
FLG
$5.96B
$171K 0.04%
3,551
+218
+7% +$10.6K
WEX icon
155
WEX
WEX
$6.42B
$166K 0.04%
1,748
+248
+17% +$22.7K
TMP icon
156
Tompkins Financial
TMP
$1.45B
$165K 0.04%
3,365
PH icon
157
Parker-Hannifin
PH
$126B
$164K 0.04%
1,366
+2
+0.1% +$240
HME
158
DELISTED
HOME PROPERTIES, INC
HME
$164K 0.04%
2,731
+226
+9% +$13.1K
KAMN
159
DELISTED
Kaman Corp
KAMN
$163K 0.04%
4,000
HD icon
160
Home Depot
HD
$352B
$161K 0.04%
2,040
+326
+19% +$25.9K
BXP icon
161
Boston Properties
BXP
$11.2B
$160K 0.04%
1,395
+1,053
+308% +$115K
MD icon
162
Pediatrix Medical
MD
$2.13B
$159K 0.04%
2,570
TMH
163
DELISTED
Team Health Holdings Inc
TMH
$159K 0.04%
3,550
TEVA icon
164
Teva Pharmaceuticals
TEVA
$40.5B
$157K 0.04%
2,973
+910
+44% +$42.1K
TSN icon
165
Tyson Foods
TSN
$20.5B
$157K 0.04%
3,568
+3,466
+3,398% +$131K
QCOM icon
166
Qualcomm
QCOM
$165B
$156K 0.04%
1,984
+998
+101% +$75.2K
FRX
167
DELISTED
FOREST LABORATORIES INC
FRX
$155K 0.04%
1,680
CL icon
168
Colgate-Palmolive
CL
$74.4B
$154K 0.04%
2,370
+340
+17% +$21.4K
SCHZ icon
169
Schwab US Aggregate Bond ETF
SCHZ
$10.5B
$153K 0.04%
+6,000
New +$153K
VGK icon
170
Vanguard FTSE Europe ETF
VGK
$31.1B
$151K 0.04%
2,560
-44,555
-95% -$2.6M
NVO
171
Novo Nordisk
NVO
$197B
$149K 0.04%
6,540
+1,520
+30% +$32.4K
WPP icon
172
WPP
WPP
$4.45B
$147K 0.04%
1,424
+436
+44% +$46.8K
NUE icon
173
Nucor
NUE
$62.6B
$145K 0.04%
2,875
CTRA
174
DELISTED
Coterra Energy
CTRA
$144K 0.04%
4,240
PICB icon
175
Invesco International Corporate Bond ETF
PICB
$362M
$142K 0.03%
4,750
-515
-10% -$15.3K

Similar funds

Howe & Rusling's Q1 2014 Portfolio in Review

As of Q1 2014, Howe & Rusling held 987 positions worth $408M, up 2.7% from $397M the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Howe & Rusling deployed $13.7M of net new capital in Q1 2014, opening 183 new positions and adding to 285 existing holdings. Its largest new stake was Jazz Pharmaceuticals: 75,535 shares worth $10.5M.

By sector, the portfolio is most concentrated in Industrials at 16% of assets, up from 16% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Bed Bath & Beyond Inc, an estimated $5.89M trimmed.

  • Howe & Rusling's largest Q1 2014 buy was Jazz Pharmaceuticals: 75,535 shares worth $10.5M.
  • Howe & Rusling added most to Ross Stores in Q1 2014, an estimated $6.58M increase.
  • Howe & Rusling's biggest Q1 2014 reduction was Bed Bath & Beyond Inc, cutting an estimated $5.89M.
  • Howe & Rusling fully exited State Street SPDR S&P 500 ETF Trust in Q1 2014, selling an estimated $3.95M.
  • Howe & Rusling's ten largest holdings make up 26% of its $408M portfolio in Q1 2014.
  • Howe & Rusling opened 183 new positions and closed 127 in Q1 2014.
  • Howe & Rusling's portfolio value rose 2.7% quarter-over-quarter to $408M.

Based on Howe & Rusling's 13F filing for Q1 2014, filed 7 May 2014.